Enhancement by neurotensin of hepatocarcinogenesis by N-nitrosomorpholine in Sprague-Dawley rats

Cancer Letters

Volumn 110, Issue 1-2, 1996, Pages 57-61

  Nakaizumi, Akihiko ^a   Uehara, Hiroyuki ^b   Baba, Miyako ^b   Iishi, Hiroyasu ^b   Tatsuta, Masaharu ^b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b NONE

Author keywords

Enhancement; Hepatocarcinogenesis; N nitrosomorpholine; Neurotensin; Placental type glutathione S transferase

Indexed keywords

DRINKING WATER; GLUTATHIONE TRANSFERASE; NEUROTENSIN; NITROSOMORPHOLINE; PLACENTA ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HISTOCHEMISTRY; LIVER CARCINOGENESIS; MALE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RAT;

ANIMALS; CARCINOGENS; DRUG SYNERGISM; GLUTATHIONE TRANSFERASE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; NEOPLASM PROTEINS; NEUROTENSIN; NITROSAMINES; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0030596174     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04466-7     Document Type: Article

References (20)

1. [1] Carraway, R. and Leeman, S.E. (1973) The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami, J. Biol. Chem., 248, 6854-6861.
2. [2] Polak, J.M., Sullivan, S.N., Bloom, S.R., Buchan, A.M., Facer, P., Brown, M.R. and Pearse, A.G. (1977) Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry, Nature, 270, 183-184.
3. [3] Walsh, J.H. (1987) Gastrointestinal hormones. In: Physiology of the Gastrointestinal Tract, Vol. 1. Editor: L.R. Johnson. Raven Press, New York, p. 181.
4. [4] Tatsuta, M., Iishi, H., Baba, M. and Taniguchi, H. (1989) Promotion by neurotensin of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats, Cancer Res., 49, 843-846.
5. [5] Tatsuta, M., Iishi, H., Baba, M. and Taniguchi, H. (1990) Enhancement by neurotensin of experimental carcinogenesis induced in rat colon by azoxymethane, Br. J. Cancer,, 62, 368-371.
6. [6] Tatsuta, M., Iishi, H., Baba, M. and Nakaizumi, A. (1991) Inhibition by neurotensin of azaserine-induced carcinogenesis in rat pancreas. Int. J. Cancer,, 47, 408-412.
7. [7] El-Salhy, M., Stenling, R. and Grimelius, L. (1993) Peptidergic innervation and endocrine cells in the human liver, Scand. J. Gastroenterol., 28, 809-815.
8. [8] Muraki, K., Nishi, Y., Arai, M., Kubo, N., Ueda, K., Shikata, H., Nakata, Y., Segawa, T., Yanaihara, N. and Yajima, H. (1987) Neurotensin receptors on the rat liver plasma membranes, Biochem. Biophys. Res. Commun., 145, 1071-1079.
9. [9] Evers, B.M., Rajaraman, S. and Chung, D.H. (1993) Developmental expression of the neurotensin gene in the rat liver, Ann. Surg., 218, 183-188.
10. [10] Sternberger, L.A., Hardy, P.H., Cuculis, J.J. and Meyer, H.G. (1970) The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes, J. Histochem. Cytochem., 18, 315-333.
11. [11] Stewart, H.L. (1980) Histologic typing of liver tumors of the rat, J. Natl. Cancer Inst., 64, 177-206.
12. [12] Gratzner, H.G. (1982) Monoclonal antibody to 5-bromo- and 5-iodo-deoxyuridine: a new reagent for detection of DNA replication, Science, 218, 474-475.
13. [13] Morstyn, G., Hsu, S.M., Kinsella, T., Gratzner, H., Russo, A. and Mitchell, J.B. (1983) Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody, J. Clin. Invest., 72, 1844-1850.
14. [14] Siegel, S. (1956) Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, New York.
15. [15] Snedecor, C.W. and Cochran, W.G. (1967) Statistical Methods. Iowa University Press, Ames, IA.
16. [16] Tatematsu, M., Mera, Y., Inoue, T., Satoh, K., Sato, K. and Ito, N. (1988) Stable phenotypic expression of glutathione S-transferase placental type and unstable phenotypic expression of 7-glutamyltransferase in rat liver preneoplastic and neoplastic lesions, Carcinogenesis, 9, 215-220.
17. [17] Miguel, E., Segura, I.A.G., Bonet, H., Montes, J.A.R. and Mata, A. (1994) Trophic effects of neurotensin in massive bowel resection in rat, Dig. Dis. Sci., 39, 59-64.
18. [18] Kawai, K., Suzuki, S., Ohashi, S., Mukai, H., Ohmori, H., Murayama, Y. and Yamashita, K. (1989) Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreas, Endocrinology, 124, 1768-1773.
19. [19] Hendrick, G., Wong, K., Lundquist, P., Nakashioma, P. and Buckley, D. (1990) Glucagon-like peptide I-(7-37) (GLP) enhances glucose disposal in vivo, Diabetes, 39, 260A.
20. [20] Hasegawa, K., Kar, S. and Carr, B.I. (1994) Stimulation of hepatocyte DNA synthesis by neurotensin, J. Cell. Physiol., 158, 215-222.